![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Dr Damian Crowther, Neuroscience, IMED Biotech Unit, AstraZeneca
Wednesday 15 November 2017, 10:30-11:30
"A TREMendous mechanism for Alzheimer's Disease: therapeutic insights"
- đ¤ Speaker: Dr Damian Crowther, Neuroscience, IMED Biotech Unit, AstraZeneca
- đ Date & Time: Wednesday 15 November 2017, 10:30 - 11:30
- đ Venue: Department of Chemistry, Cambridge, Unilever lecture theatre
Questions? Contact
Patrick Flagmeier
Abstract
TREM2 is arguably the most potent genetic risk factor for sporadic Alzheimer’s disease. It is a scavenger receptor recognising generic molecular patterns on cellular debris and amyloid fibrils. Reduced levels of TREM2 on the surface of the brain’s phagocytic cells, the microglia, is associated with disease risk. Protecting TREM2 from proteolytic shedding from the microglial surface is a potential therapeutic goal.
Series This talk is part of the Biophysical Seminars series.
Included in Lists
- All Talks (aka the CURE list)
- Biophysical Seminars
- Biophysical Seminar Series 2016/17
- Department of Chemistry
- Department of Chemistry, Cambridge, Unilever lecture theatre
- Featured lists
- School of Physical Sciences
Note: Ex-directory lists are not shown.